102 related articles for article (PubMed ID: 11679560)
1. Comparative study of new benzenesulphonamide fluoroquinolones structurally related to ciprofloxacin against selected ciprofloxacin-susceptible and -resistant Gram-positive cocci.
Alovero F; Barnes A; Nieto M; Mazzieri MR; Manzo RH
J Antimicrob Chemother; 2001 Nov; 48(5):709-12. PubMed ID: 11679560
[TBL] [Abstract][Full Text] [Related]
2. Comparative in-vitro activity of the new fluoroquinolone trovafloxacin (CP-99,219) against gram-positive cocci.
Coque TM; Singh KV; Murray BE
J Antimicrob Chemother; 1996 May; 37(5):1011-6. PubMed ID: 8737152
[TBL] [Abstract][Full Text] [Related]
3. In vitro susceptibility of recent gram-positive isolates to ciprofloxacin, levofloxacin, and trovafloxacin.
Isenberg HD; Alperstein P; France K
Diagn Microbiol Infect Dis; 1998 Oct; 32(2):115-8. PubMed ID: 9823535
[TBL] [Abstract][Full Text] [Related]
4. Activity of moxifloxacin against pathogens with decreased susceptibility to ciprofloxacin.
Pong A; Thomson KS; Moland ES; Chartrand SA; Sanders CC
J Antimicrob Chemother; 1999 Nov; 44(5):621-7. PubMed ID: 10552978
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial activity of gatifloxacin tested against 1676 strains of ciprofloxacin-resistant gram-positive cocci isolated from patient infections in North and South America.
Jones RN; Beach ML; Pfaller MA; Doern GV
Diagn Microbiol Infect Dis; 1998 Nov; 32(3):247-52. PubMed ID: 9884844
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of clinafloxacin against fluoroquinolone resistant Spanish clinical isolates.
López-Brea M; Prieto N; Domingo D; de las Cuevas C; Sánchez I; Alarcón T
Int J Antimicrob Agents; 1999 Jun; 12(1):33-9. PubMed ID: 10389645
[TBL] [Abstract][Full Text] [Related]
7. Comparative in vitro activity of DU-6859a, a new fluoroquinolone agent, against gram-positive cocci.
Korten V; Tomayko JF; Murray BE
Antimicrob Agents Chemother; 1994 Mar; 38(3):611-5. PubMed ID: 8203863
[TBL] [Abstract][Full Text] [Related]
8. Comparative in vitro activity of PD 127391, a new fluoroquinolone agent, against susceptible and resistant clinical isolates of gram-positive cocci.
Miranda AG; Wanger AR; Singh KV; Murray BE
Antimicrob Agents Chemother; 1992 Jun; 36(6):1325-8. PubMed ID: 1329621
[TBL] [Abstract][Full Text] [Related]
9. Comparative in vitro activities of ciprofloxacin, gemifloxacin, grepafloxacin, moxifloxacin, ofloxacin, sparfloxacin, trovafloxacin, and other antimicrobial agents against bloodstream isolates of gram-positive cocci.
Hardy D; Amsterdam D; Mandell LA; Rotstein C
Antimicrob Agents Chemother; 2000 Mar; 44(3):802-5. PubMed ID: 10681365
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of temafloxacin against gram-positive cocci including methicillin-resistant Staphylococcus aureus.
Fuchs PC
Am J Med; 1991 Dec; 91(6A):15S-18S. PubMed ID: 1662886
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of sparfloxacin (CI-978), a new broad-spectrum fluoroquinolone.
Qadri SM; Ueno Y; Burns JJ; Almodovar E; Rabea N
Chemotherapy; 1992; 38(2):99-106. PubMed ID: 1317282
[TBL] [Abstract][Full Text] [Related]
12. Activity and spectrum of BMS 284756, a new des-F (6) quinolone, tested against strains of ciprofloxacin-resistant Gram-positive cocci.
Jones RN; Pfaller MA; Stilwell M;
Diagn Microbiol Infect Dis; 2001 Feb; 39(2):133-5. PubMed ID: 11248528
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of CP-74667 compared with four other fluoroquinolones.
Jones RN; Erwin ME
Diagn Microbiol Infect Dis; 1992 Aug; 15(6):531-6. PubMed ID: 1330419
[TBL] [Abstract][Full Text] [Related]
14. [Resistance profiles to fluoroquinolones in clinical isolates of Gram positive cocci].
Hidalgo M; Reyes J; Cárdenas AM; Díaz L; Rincón S; Vanegas N; Díaz PL; Castañeda E; Arias CA
Biomedica; 2008 Jun; 28(2):284-94. PubMed ID: 18719726
[TBL] [Abstract][Full Text] [Related]
15. In vitro activities of DX-619 and comparison quinolones against gram-positive cocci.
Wickman PA; Black JA; Moland ES; Thomson KS
Antimicrob Agents Chemother; 2006 Jun; 50(6):2255-7. PubMed ID: 16723599
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of LY333328 (oritavancin) against Gram-positive aerobic cocci and synergy with ciprofloxacin against enterococci.
Noviello S; Ianniello F; Esposito S
J Antimicrob Chemother; 2001 Aug; 48(2):283-6. PubMed ID: 11481302
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility of ciprofloxacin-resistant staphylococci and enterococci to clinafloxacin.
Harrington GD; Zarins LT; Ramsey MA; Bradley SF; Kauffman CA
Diagn Microbiol Infect Dis; 1995 Jan; 21(1):27-31. PubMed ID: 7789094
[TBL] [Abstract][Full Text] [Related]
18. SYN987, SYN1193, and SYN1253, new quinolones highly active against gram-positive cocci.
Kitzis MD; Goldstein FW; Ishida N; Acar JF
J Antimicrob Chemother; 1995 Jul; 36(1):209-13. PubMed ID: 8537267
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of E-4868, a new fluoroquinolone with a 7-azetidin ring, compared with ciprofloxacin, ofloxacin and fleroxacin.
Mirelis B; Navarro F; Miró E; Coll R; Xicota MA; Prats G
Drugs Exp Clin Res; 1995; 21(4):129-38. PubMed ID: 8529525
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of the in vitro activity of a new fluoroquinolone, ABT-492.
Harnett SJ; Fraise AP; Andrews JM; Jevons G; Brenwald NP; Wise R
J Antimicrob Chemother; 2004 May; 53(5):783-92. PubMed ID: 15056651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
